Trial Profile
A First in Human Phase 1 trial of OPN 305 in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Feb 2015
Price :
$35
*
At a glance
- Drugs Tomaralimab (Primary)
- Indications Delayed graft function
- Focus Adverse reactions; First in man
- Sponsors Opsona Therapeutics
- 28 Feb 2015 New trial record